Latest News

• share
• favorite_border

A donation from the Thomas J. Beatson, Jr. Foundation will broaden access to Joslin's care ambassadors program for youth newly diagnosed with diabetes.

• share
• favorite_border

Patient centers will bring advances in diabetes care to Southeast Texas.

• share
• favorite_border

Web site features trilingual support, interactive nutrition guides for Asian meals and other culturally relevant information.

• share
• favorite_border

Joslin scientists nail down proof that some people with type 1 diabetes of extreme duration retain active insulin-producing cells.

• share
• favorite_border

The Mustang, the car that "changed everything" in the automotive industry, will now contribute to finding a cure for diabetes.

• share
• favorite_border

Joslin research finds natural mechanisms in insulin-producing cells that may be enhanced to aid type 1 diabetes treatments.

• share
• favorite_border

Joslin scientists discover mechanism that lowers insulin secretion in type 2 diabetes.

• share
• favorite_border

Boston life sciences leader provides expertise to world’s leading diabetes research and clinical care organization.

• share
• favorite_border

Harvard affiliates aid in establishing a comprehensive program for diabetes care, management and research

• share
• favorite_border

Long suspected of worsening artery damage in patients with diabetes, insulin instead protects blood vessels, a new study by Joslin Diabetes Center scientists indicates.

• share
• favorite_border

Joslin scientists find surprising twist in PI 3-kinase molecule that may offer novel target for diabetes drugs.

• share
• favorite_border

Salsalate, an anti-inflammatory agent, shows encouraging results in preliminary trial led by Joslin Diabetes Center.

• share
• favorite_border

Finding by Joslin Diabetes Center scientists may aid in understanding how insulin production eventually goes wrong in type 2 diabetes.

• share
• favorite_border

New collaboration leverages Joslin’s deep clinical and research expertise and dLife’s community and lifestyle approach to managing diabetes.

• share
• favorite_border

Joslin Diabetes Center scientists uncover clues toward treating age-related conditions via the blood.

• share
• favorite_border

In people who put on a lot of weight, or whose bodies start developing the inability to use insulin effectively that leads toward type 2 diabetes, the pancreas typically ramps up its supply of insulin-generating “beta” cells. Researchers at Joslin Diabetes Center and their colleagues now have identified a cell-cycle protein that is essential for beta-cell replication to respond successfully to insulin resistance. The finding may point toward eventual therapies for preventing or treating type 2 diabetes.

• share
• favorite_border

Joslin scientists discover that high blood glucose levels damage a key enzyme that guards against oxidative stress in beta cells.

• share
• favorite_border

Brown fat finding is declared one of the most important scientific accomplishments of 2009.

• share
• favorite_border

Over time, patients with type 2 diabetes lose insulin-producing cells, a difficulty that aggravates their disease. Researchers at Joslin Diabetes Center now have identified a mechanism that triggers the problem, giving a chance to find targets for drugs to protect these crucial cells.

• share
• favorite_border

Joslin Diabetes Center scientists discover new route by which high blood glucose levels damage eyes.

• share
• favorite_border

Weight management underlies a successful new approach to type 2 diabetes care at Joslin Diabetes Center.

• share
• favorite_border

Researchers at the Joslin Diabetes Center have linked another gene to a rare form of diabetes, a finding that could prove beneficial to those with the more common type 2 diabetes.

• share
• favorite_border

Researchers at the Joslin Diabetes Center have for the first time linked high levels of glutamate "“ a neurotransmitter in the brain produced from glucose "“ in people with type 1 diabetes to symptoms of depression and lower levels of cognitive performance.

• share
• favorite_border

The Association for Research in Vision and Ophthalmology (ARVO) is honored to announce this year's inaugural class of distinguished Fellows. Lloyd Paul Aiello, M.D., PhD, head of the Joslin Section on Eye Research, was among the group of members recognized for their accomplishments, leadership and contributions to the Association.

• share
• favorite_border

Joslin Diabetes Center today announced that Enrique Caballero, M.D., director of Joslin's Latino Diabetes Initiative (LDI), has been named the 2009 recipient of the Bernardo Alberto Houssay Award.

• share
• favorite_border

Joslin Diabetes Center today announced the opening of the Joslin Diabetes Center Affiliate at the Dubai Health Authority (DHA).

• share
• favorite_border

Researchers at the Joslin Diabetes Center have demonstrated that adult humans still have a type of "good" fat previously believed to be present only in babies and children.

• share
• favorite_border

Researchers at the Joslin Diabetes Center have shown for the first time that insulin plays a key role in suppressing levels of glucagon, a hormone involved in carbohydrate metabolism and regulating blood glucose levels.

• share
• favorite_border

Joslin Diabetes Center today announced Richard R. Crater as chief financial officer. Crater brings to Joslin more than 30 years of experience, including positions as chief financial officer at New York University Medical Center and The Massachusetts General Hospital (MGH). In his new role, Crater will be responsible for overall financial management and operational planning at the Joslin.

• share
• favorite_border

Joslin Diabetes Center scientists have launched a national clinical trial to investigate whether salsalate, an anti-inflammatory drug used for years to manage arthritis, can reduce blood glucose levels in people with type 2 diabetes.

• share
• favorite_border

Joslin Diabetes Center today announced it has received a $1 million gift from the Thomas J. Beatson, Jr. Foundation to support type 1 diabetes research.

• share
• favorite_border

Three-quarters of youths with type 1 diabetes were found to have insufficient levels of vitamin D, according to a study by researchers at the Joslin Diabetes Center.

• share
• favorite_border

A new study led by researchers at the Joslin Diabetes Center and Harvard Medical School has found that a common genetic variant associated with an increased risk of coronary artery disease (CAD) in the general population is also linked to an even higher risk for people with diabetes, particularly those with poor glucose control.

• share
• favorite_border

Researchers at the Joslin Diabetes Center have shown that insulin-producing pancreatic beta cells can form after birth or after injury from progenitor cells within the pancreas that were not beta cells.

• share
• favorite_border

C. Ronald Kahn, M.D., Head of the Joslin Section on Obesity and Hormone Action and the Mary K. Iacocca Professor of Medicine at Harvard Medical School, has been named the first winner of the Manpei Suzuki International Prize for Diabetes Research.

• share
• favorite_border

Joslin Diabetes Center today announced it has received a three-year, $3 million grant from the Eli Lilly and Company Foundation to help fund studies that will investigate the underlying causes of obesity and insulin resistance "“ two leading risk factors for diabetes and heart disease.

• share
• favorite_border

Joslin Diabetes Center today announced the introduction of the Joslin Professional Education Consortium (JPEC), a unique, comprehensive, Web-based resource and community for primary care physicians (PCPs) focused on treating diabetes and its complications.

• share
• favorite_border

A study by researchers from the Joslin Diabetes Center has shown for the first time that more than half of patients with type 2 diabetes who enrolled in a novel short-term weight management program were able to maintain the weight loss they achieved during the program on their own long-term.

• share
• favorite_border

A study by researchers at the Joslin Diabetes Center has shown that a protein known for its role in inducing bone growth can also help promote the development of brown fat, a "good" fat that helps in the expenditure of energy and plays a role in fighting obesity.

• share
• favorite_border

Researchers at the Joslin Diabetes Center have demonstrated for the first time that transplanted muscle stem cells can both improve muscle function in animals with a form of muscular dystrophy and replenish the stem cell population for use in the repair of future muscle injuries.

• share
• favorite_border

A study by researchers at the Joslin Diabetes Center has shown that adherence to prescribed dietary recommendations is associated with better glucose control in children with type 1 diabetes.

• share
• favorite_border

Clinicians across America now have access to the knowledge and opinions of a renowned diabetes expert, thanks to a collaboration between Joslin Diabetes Center Epocrates Inc.

• share
• favorite_border

Scientists at the Joslin Diabetes Center in Boston have found that a defect in the beta cells that make and release insulin has implications for the failure of these cells and the development of type 2 diabetes.

• share
• favorite_border

Researchers at the Joslin Diabetes Center in Boston have discovered that a significant portion of people who have had type 1 diabetes for 50 or more years still have the capacity to produce insulin.

• share
• favorite_border

Researchers from the Joslin Diabetes Center in Boston have shown for the first time that patients with diabetes who enrolled in a short-term weight management program were able to maintain the weight loss they achieved during the program on their own long-term.

• share
• favorite_border

Using a novel investigatory technique, researchers at the Joslin Diabetes Center have established that osteoblasts, cells responsible for bone formation, are also directly involved in the proliferation and expansion of blood-forming hematopoietic stem cells.

• share
• favorite_border

Researchers at the Joslin Diabetes Center who reported earlier this year that an inexpensive, non-steroidal anti-inflammatory drug called salsalate might prevent type 2 diabetes are now reporting that the drug may also be beneficial in the treatment of the disease.

• share
• favorite_border

Researchers at the Joslin Diabetes Center have found that subcutaneous fat can reduce insulin resistance and improve insulin sensitivity.

• share
• favorite_border

Researchers at the Joslin Diabetes Center have identified a gene that is responsible for the division and movement of marrow-derived, blood-forming stem cells, a finding that could have major implications for the future of bone marrow and blood cell transplantation.

• share
• favorite_border

Researchers at the Joslin Diabetes Center have shown that insulin has a previously unknown effect that plays a role in aging and lifespan, a finding that could ultimately provide a mechanism for gene manipulations that could help people live longer and healthier lives.